达芬奇Xi与Si机器人直肠癌全直肠系膜切除术短期手术与功能结局的病例匹配比较
该研究将连续30例达芬奇Xi机器人直肠癌全直肠系膜切除术(Xi-RobTME)与30例Si机器人手术(Si-RobTME)按1:1病例匹配比较。结果显示Xi组对接时间和总手术时间更短,完全机器人入路比例更高,但中转率、住院时间、病理数据及功能结局无差异。
要点
- Xi机器人对接时间与总手术时间均短于Si机器人。
- Xi组完全机器人入路行脾曲完全游离的比例为100%,Si组为23%。
- 两组中转率、住院时间、病理数据及术后1年功能结局无差异。
核心结论
- 达芬奇Xi的技术优势主要体现在更短的对接时间和手术时间,以及更强的完全机器人入路能力。
- Xi平台并未改善临床和功能结局。
研究设计与样本
- 病例匹配比较研究,Xi-RobTME组为连续30例,Si-RobTME对照组为30例。
- Si组通过一对一病例匹配方法从前瞻性机构数据库中选取,手术时间为2010年4月至2016年9月,均由同一外科医生完成。
主要发现
- Xi-RobTME组对接时间和总手术时间更短(p < 0.001和p < 0.05)。
- 总手术时间平均差异为-33.8 min(95% CI -5.1 to -64.5),对接时间平均差异为-6 min(95% CI -4.1 to -7.9)。
- 完全机器人入路行脾曲完全游离在Xi组为30/30(100%),Si组为7/30(23%)(p < 0.001)。
- Si组男性及BMI > 25 kg/m2患者需杂交入路者分别为十例(45 vs. 0%,p < 0.001)和六例(37 vs. 0%,p < 0.05)。
- 两组中转率、平均住院时间、病理数据及术前和术后1年功能结局无差异。
临床怎么用
- 在机器人直肠癌TME中,Xi平台可缩短对接和手术时间,并更易完成完全机器人脾曲游离。
- 选择平台时需权衡技术优势与临床功能结局无差异的现实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic rectal resection with da Vinci Si has some technical limitations, which could be overcome by the new da Vinci Xi. We compare short-term surgical and functional outcomes following robotic rectal resection with total mesorectal excision for cancer, with the da Vinci Xi (Xi-RobTME group) and the da Vinci Si (Si-RobTME group). METHODS: The first consecutive 30 Xi-RobTME were compared with a Si-RobTME control group of 30 patients, selected using a one-to-one case-matched methodology from our prospectively collected Institutional database, comprising all cases performed between April 2010 and September 2016 by a single surgeon. Perioperative outcomes were compared. The impact of minimally invasive TME on autonomic function and quality of life was analyzed with specific questionnaires. RESULTS: The docking and overall operative time were shorter in the Xi-RobTME group (p < 0.001 and p < 0.05 respectively). The mean differences of overall operative time and docking time were -33.8 min (95% CI -5.1 to -64.5) and -6 min (95% CI -4.1 to -7.9), respectively. A fully-robotic approach with complete splenic flexure mobilization was used in 30/30 (100%) of the Xi-RobTME cases and in 7/30 (23%) of the Si-RobTME group (p < 0.001). The hybrid approach in males and patients with BMI > 25 kg/m2 was necessary in ten patients (45 vs. 0%, p < 0.001) and in six patients (37 vs. 0%, p < 0.05), in the Si-RobTME and Xi-RobTME groups, respectively. There were no differences in conversion rate, mean hospital stay, pathological data, and in functional outcomes between the two groups before and at 1 year after surgery. CONCLUSION: The technical advantages offered by the da Vinci Xi seem to be mainly associated with a shorter docking and operative time and with superior ability to perform a fully-robotic approach. Clinical and functional outcomes seem not to be improved, with the introduction of the new Xi platform.
引用
- Morelli L, Di Franco G, Guadagni S, et al. Robot-assisted total mesorectal excision for rectal cancer: case-matched comparison of short-term surgical and functional outcomes between the da Vinci Xi and Si. Surg Endosc. 2017. PMID: 28733738. doi:10.1007/s00464-017-5708-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。